InvestorsHub Logo
Followers 16
Posts 3994
Boards Moderated 0
Alias Born 01/12/2004

Re: otclife post# 94

Friday, 01/12/2018 11:04:58 AM

Friday, January 12, 2018 11:04:58 AM

Post# of 660
I agree about the overreaction. Bummer that one trial for one indication didn't succeed, but they have a great pipeline with multiple drugs for multiple indications and the majority of components they use are already approved by the FDA.
CPRS would have been huge, but it didn't work out. Knee OA is still a huge market and with their drugs being non-opioid, there is phenomenal upside with AXSM. I am buying down here as well.
GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXSM News